X
Record #72967

Exploring novel fluorine-rich fuberidazole derivatives as hypoxic cancer inhibitors: Design, synthesis, pharmacokinetics, molecular docking, and DFT evaluations

Journal
PLoS One
Publisher
PLoS
Original paper date
Feb 2, 2023
Institution
Division of Inorganic Chemistry, Institute of Chemistry, Islamia University Bahawalpur, Bahawalpur, Pakistan · Department of Chemistry, Quaid-e-Azam University, Islamabad, Pakistan · Department of Organic Chemistry, Arrhenius Laboratory, Stockholm University, Stockholm, Sweden · Department of Biochemistry, College of Science, University of Jeddah, Jeddah, Saudi Arabia · Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia · Department of Physiology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia · Department of Chemistry, Govt. College Women University, Faisalabad, Pakistan · Research Center for Advanced Materials Science (RCAMS), King Khalid University, Abha, Saudi Arabia · Department of Chemistry, College of Science, King Khalid University, Abha, Saudi Arabia · Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Sihhiye, Ankara-Turkey · Department of Forensic Medicine and Clinical Toxicology, Menoufia University, Shbien El-Kom, Egypt
Open access
No
Article type
Research Article
Broad categories
(BLS) Biology - Molecular(HSC) Medicine - Oncology(HSC) Medicine - Pharmacology
Citation lifecycle

How this paper is being cited

Pre-retraction
4
Same day
0
Post-retraction
0
% post-retraction
0.0%
~1.2 citations/yr before retraction
— citing papers

Who is still citing this work

Loading…
Back to browse